Clinical Trials
4 trialsNCT06295731 2026-05-08
HexAgon-HN
Inhibrx Biosciences, Inc
Phase 2/3 Active not recruiting
NCT04198766 2025-12-18
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Inhibrx Biosciences, Inc
Phase 1/2 Active not recruiting
NCT03039465 2017-02-01
TEP
HealthCare Global Enterprise Ltd.
Phase NA Unknown
NCT00080028 2007-05-08
Motexafin Gadolinium With Chemotherapy and Radiation Therapy for the Treatment of Advanced Head and Neck Cancer
Pharmacyclics LLC.
Phase 1 Terminated